ArticleJAMA oncology2022

Expanded Parameters in Active Surveillance for Low-risk Papillary Thyroid Carcinoma: A Nonrandomized Controlled Trial.

Allen S Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.